The people behind PathGen
PathGen is built by one consortium across five institutions — Duke-NUS, IXO, Sequentia Biotech, the University of Sydney and AWS.
Directory
15 people
Riccardo Aiese Cigliano — profile, opens in a new tab
Scientific Director and Co-founder
Sequentia Biotech
Dr Michael Barber — profile, opens in a new tab
Adjunct Assistant Professor & Data Lead
Duke-NUS Medical School, IXO
Lei Jingyi — profile, opens in a new tab
Research Associate
Centre for Outbreak Preparedness, Duke-NUS
Prof Paul Michael Pronyk — profile, opens in a new tab
Principal Investigator & Director, Centre for Outbreak Preparedness
Duke-NUS Medical School
Prof Vitali Sintchenko — profile, opens in a new tab
Sydney Infectious Diseases Institute
University of Sydney
